3,354 research outputs found
RG Flow from Theory to the 2D Ising Model
We study 1+1 dimensional theory using the recently proposed method
of conformal truncation. Starting in the UV CFT of free field theory, we
construct a complete basis of states with definite conformal Casimir,
. We use these states to express the Hamiltonian of the full
interacting theory in lightcone quantization. After truncating to states with
, we numerically diagonalize the
Hamiltonian at strong coupling and study the resulting IR dynamics. We compute
non-perturbative spectral densities of several local operators, which are
equivalent to real-time, infinite-volume correlation functions. These spectral
densities, which include the Zamolodchikov -function along the full RG flow,
are calculable at any value of the coupling. Near criticality, our numerical
results reproduce correlation functions in the 2D Ising model.Comment: 31+12 page
Times are changing, but has natural mortality? Estimation of mortality rates for tropical tunas in the western and central Pacific Ocean
Midlatitude, Rayleigh-Mie-Raman Lidar for Observations from 15 to 120 km
Rayleigh lidar opened a portion of the atmosphere, from 30 to 90 km, to ground-based observations. Rayleigh-scatter observations were made at the Atmospheric Lidar Observatory (ALO) at Utah State University (USU) from 1993–2004 between 45 and 90 km. The lidar consisted of a 0.44-m diameter mirror, a frequency-doubled Nd:YAG laser opera\u27ng at 532-nm at 30- Hz at either 18- or 24-W, giving power- aperture products (PAPs) of 2.7- or 3.6- Wm2, respec\u27vely, and one detector channel. An example of what was accomplished with this system is shown as part of Fig. 1. The temperature climatology was based on ~5000 hours of observa\u27ons carried out over ~900 nights. The temperatures, with 3-km al\u27tude resolu\u27on, were averaged over periods of 31 days by 11 years.
The ALO Rayleigh lidar is currently being upgraded, as indicated, as indicated in Fig. 1, to extend observations upward into the lower thermosphere and downward to the lower stratosphere
Mid-Latiude Rayleigh-Mie-Raman Lidar for Observations from 15 to 120 km
Rayleigh lidar opened a portion of the atmosphere, from 30 to 90 km, to ground-based observations. Rayleigh-scatter observations were made at the Atmospheric Lidar Observatory (ALO) at Utah State University (USU) from 1993–2004 between 45 and 90 km. The lidar consisted of a 0.44-m diameter mirror, a frequency-doubled Nd:YAG laser opera\u27ng at 532-nm at 30- Hz at either 18- or 24-W, giving power- aperture products (PAPs) of 2.7- or 3.6- Wm2, respec\u27vely, and one detector channel. An example of what was accomplished with this system is shown as part of Fig. 1. The temperature climatology was based on ~5000 hours of observa\u27ons carried out over ~900 nights. The temperatures, with 3-km al\u27tude resolu\u27on, were averaged over periods of 31 days by 11 years.
The ALO Rayleigh lidar is currently being upgraded, as indicated, as indicated in Fig. 1, to extend observations upward into the lower thermosphere and downward to the lower stratosphere
Rayleigh Lidar Temperature Studies in the Upper Mesosphere and Lower Thermosphere
Rayleigh lidar technology opened the middle atmosphere (from 30–90 km) to ground-based observations. The upgraded system at the Atmospheric Lidar Observatory (ALO) on the campus of Utah State University (41.74, 111.81) has shown that these ground-based observations can be extended to 109 km, with the goal of reaching 120 km. The resultant study of short and long-term temperature trends, using Rayleigh lidar, contributes immensely to the overall understanding of the properties and dominant physical processes in the middle atmosphere and Mesosphere-Lower Thermosphere (MLT) region. Temperature variations on short time scales, from minutes to days, give insight into the effects of waves (gravity waves, tides, planetary waves), while climatological studies of temperatures can help in the study of global change throughout the atmosphere
Gallus GBrowse: a unified genomic database for the chicken
Gallus GBrowse (http://birdbase.net/cgi-bin/gbrowse/gallus/) provides online access to genomic and other information about the chicken, Gallus gallus. The information provided by this resource includes predicted genes and Gene Ontology (GO) terms, links to Gallus In Situ Hybridization Analysis (GEISHA), Unigene and Reactome, the genomic positions of chicken genetic markers, SNPs and microarray probes, and mappings from turkey, condor and zebra finch DNA and EST sequences to the chicken genome. We also provide a BLAT server (http://birdbase.net/cgi-bin/webBlat) for matching user-provided sequences to the chicken genome. These tools make the Gallus GBrowse server a valuable resource for researchers seeking genomic information regarding the chicken and other avian species
Rayleigh Lidar Observations of the Mid-Latitude Mesosphere During Stratospheric Warming Events and a New Rayleigh-Mie-Raman Lidar at USU
Targeting Ribosome Assembly Factors Selectively Protects p53 Positive Cells from Chemotherapeutic Agents
Many chemotherapeutic agents act in a nondiscriminatory fashion, targeting both cancerous and noncancerous cells in Sphase and Mphase. One approach to reduce the toxic side effects in normal tissue is to exploit the differences in p53 functionality between cancerous and noncancerous cells. For example, activating p53 signaling by nongenotoxic means can transiently arrest noncancerous p53 positive cells in G1 phase and protect them from the cytotoxic effects of chemotherapeutic drugs. However, since most cancerous cells have faulty p53 signaling, they will proceed to cycle, and continue to be affected by the drug. In this study we asked if this G1‐phase arrest and cytoprotection can be achieved by targeting ribosome biogenesis. Through the expression of a dominant negative mutant ribosome assembly factor Bop1, we were able to transiently inhibit rRNA maturation. Using this genetic model, we have shown that inhibition of rRNA maturation protects 3T3 cells from chemotherapeutic agents camptothecin and methotrexate
- …